Fmoc-D-glutamic acid α-allyl ester is a protected, derivatized glutamic acid in which the α-carboxyl group is esterified with an allyl group and the α-amino functionality is protected as an Fmoc carbamate, with D stereochemistry specified in the product name. The molecule therefore contains an Fmoc-protected amine, an allyl ester at the α-position, and a glutamate side chain bearing a carboxylic acid that remains available for further coupling or salt formation, while the allyl substituent provides an orthogonal handle for downstream transformations. In peptide and amino-acid derivative synthesis, this protected amino acid is used as a building block for stepwise assembly where the Fmoc group supports controlled amine deprotection and the α-allyl ester can function as a temporary protecting/functional group for chemoselective manipulations during synthesis and subsequent derivatization.
CAT No: CP00726
Fmoc-D-glutamic acid α-allyl ester is a D-configured glutamate derivative bearing an Fmoc-protected amino group and an α-allyl ester at the carboxyl terminus, providing a chiral amino acid ester suitable for stepwise peptide construction. The molecule contains a stereogenic center at the glutamate α-carbon, a side-chain carboxyl functionality masked as part of the glutamate framework, and an allyl ester that can be selectively transformed under orthogonal deprotection conditions. The Fmoc carbamate introduces base-labile protection for Nα during solid-phase or solution-phase coupling, while the allyl ester can participate in downstream functionalization routes that require ester stability during assembly. The overall reactivity profile supports peptide coupling chemistry, orthogonal protection/deprotection strategies, and conversion into glutamate-derived intermediates for synthetic, biochemical, and industrial workflows.
1. Peptide Synthesis
Fmoc-D-glutamic acid α-allyl ester is applied in peptide building-block preparation where Fmoc protection enables controlled Nα deprotection and subsequent amide bond formation. The glutamate backbone provides the spacing and functional group pattern characteristic of acidic residues, while the α-allyl ester supports orthogonal handling of the C-terminal functionality during peptide assembly. Allyl ester stability under typical coupling conditions can allow sequential chain elongation, followed by ester transformation to generate C-terminally modified peptide fragments or activated carboxylates for further derivatization. Downstream peptide analogs prepared from this protected amino acid ester can be used in research-grade libraries and in process development for peptide intermediates requiring stereodefined D-glutamate incorporation.
2. Side-Chain Functionalization
Fmoc-D-glutamic acid α-allyl ester is suitable for side-chain and terminus functionalization strategies that leverage the allyl ester as a handle for controlled conversion to carboxylic acid derivatives. The allyl ester can be used to access C-terminal carboxyl forms or to introduce functional moieties through derivatization steps that maintain the D-stereochemical identity at the α-carbon. The Fmoc group allows the compound to be carried through protection-compatible transformations, enabling orthogonal sequencing where N-protection is removed independently from ester modification. Resulting glutamate-based intermediates can feed into peptidomimetic construction, linker installation, and preparation of acid-bearing fragments used for structure-activity relationship studies and synthetic methodology development.
3. Chiral Amino Acid Intermediate
Fmoc-D-glutamic acid α-allyl ester functions as a chiral amino acid intermediate for stereocontrolled synthesis of D-glutamate-containing molecules. The D-configuration at the α-carbon is preserved through Fmoc-mediated N-protection and allyl ester masking, supporting downstream conversion into chiral carboxylic acid derivatives and activated glutamate equivalents. The orthogonal protection pattern enables selective deprotection logic, where Nα deprotection and ester conversion can be tuned to match the requirements of subsequent coupling, amidation, or fragment assembly. This stereodefined intermediate can be employed in fine chemical synthesis and in the manufacture of peptide reagents and chiral building blocks used across synthetic organic chemistry and biochemical research.
4. Bioconjugation Chemistry
Fmoc-D-glutamic acid α-allyl ester can be used in bioconjugation workflows that require glutamate-derived linkers with controlled C-terminal functionality and defined stereochemistry. The Fmoc-protected amino group supports preparation of peptide-like conjugation units that can later be deprotected to enable coupling to biomolecular targets or to reactive handles on surfaces and scaffolds. The allyl ester provides a chemical switch for generating carboxylate forms suitable for subsequent activation chemistry, enabling attachment of glutamate-based motifs to proteins, peptides, or polymeric carriers. D-glutamate incorporation can be relevant for conjugate stability and recognition studies where stereochemistry influences binding or proteolytic resistance in biochemical assay contexts.
5. Pharmaceutical Intermediate Preparation
Fmoc-D-glutamic acid α-allyl ester is relevant to pharmaceutical intermediate preparation where protected amino acid esters are used to build defined acidic residue motifs in drug-like scaffolds and peptide-based candidates. The Fmoc carbamate enables manufacturing-compatible protection of the amino functionality during sequential coupling and purification steps, while the allyl ester supports orthogonal conversion to carboxylic acid derivatives used for further functional group transformations. The chiral glutamate framework supports stereochemically defined intermediate generation for downstream synthesis of peptidomimetics, linker-carboxyl units, and terminally functionalized fragments. The resulting intermediates can be integrated into process chemistry routes for producing peptide building blocks and related fine chemicals with controlled stereochemical composition.
6. Analytical Research Standards
Fmoc-D-glutamic acid α-allyl ester can serve as an analytical reference material precursor for method development targeting protected glutamate derivatives and their deprotected or derivatized forms. The combination of Fmoc and an allyl ester creates distinct chromatographic and mass spectrometric signatures that can aid in monitoring deprotection, ester conversion, and peptide coupling progress in analytical workflows. The stereodefined D-glutamate configuration supports stereospecific studies where separation or confirmation of stereochemical identity is required for protected amino acid synthesis and peptide assembly verification. Downstream derivatization from this intermediate can generate standards for impurity profiling, reaction monitoring, and characterization of glutamate-containing peptide fragments used in biochemical research and industrial quality control.
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More